GSK Consumer Healthcare Q1 profit up 8.46 pc at Rs 130.12 cr

GlaxoSmithKline Consumer Healthcare today posted 8.46 per cent increase in net profit at Rs 130.12 crore for the first quarter ended June 30, 2014 due to growth in all categories.
The company had reported net profit of Rs 119.96 crore in the same quarter a year ago.
Net sales of the company rose by 8.04 per cent to Rs 921.55 crore in the April-June quarter as against Rs 852.92 crore in the corresponding period last year,
"This is significant in a scenario where consumption pattern is being impacted by inflation. Our sciences based products with its superior value, continue to remain relevant for our large consumer base," GlaxoSmithKline Consumer Healthcare Managing Director Zubair Ahmed said in a statement.

As a market leader, the company is also growing the category with successful launches of new products which are driving up consumption experiences, he added.
On the future outlook of the company, Ahmed said: "Customer driven innovations and clutter breaking marketing based on sharp consumer insights will continue to be our driving force in the coming months to bring in more consumers closer to the product".
Further, the company said it has appointed Sangeeta Talwar as an independent director.
Shares of the company today closed at Rs 4,873.40 apiece on the BSE, down 1.78 per cent from previous close.